It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mitochondria in neural progenitors play a crucial role in adult hippocampal neurogenesis by being involved in fate decisions for differentiation. However, the molecular mechanisms by which mitochondria are related to the genetic regulation of neuronal differentiation in neural progenitors are poorly understood. Here, we show that mitochondrial dysfunction induced by amyloid-beta (Aβ) in neural progenitors inhibits neuronal differentiation but has no effect on the neural progenitor stage. In line with the phenotypes shown in Alzheimer’s disease (AD) model mice, Aβ-induced mitochondrial damage in neural progenitors results in deficits in adult hippocampal neurogenesis and cognitive function. Based on hippocampal proteome changes after mitochondrial damage in neural progenitors identified through proteomic analysis, we found that lysine demethylase 5A (KDM5A) in neural progenitors epigenetically suppresses differentiation in response to mitochondrial damage. Mitochondrial damage characteristically causes KDM5A degradation in neural progenitors. Since KDM5A also binds to and activates neuronal genes involved in the early stage of differentiation, functional inhibition of KDM5A consequently inhibits adult hippocampal neurogenesis. We suggest that mitochondria in neural progenitors serve as the checkpoint for neuronal differentiation via KDM5A. Our findings not only reveal a cell-type-specific role of mitochondria but also suggest a new role of KDM5A in neural progenitors as a mediator of retrograde signaling from mitochondria to the nucleus, reflecting the mitochondrial status.
Alzheimer’s disease: a molecular link with mitochondrial damage
Neural Stem cells in the brain that normally generate new neurons throughout life can become dysfunctional due to damage caused by the protein amyloid-beta to mitochondria, the intracellular energy-producing structures. Neuron generation is reduced in Alzheimer’s disease, therefore understanding its causes could lead to new treatments. Dong Kyu Kim at Seoul National University, South Korea, and colleagues studied neuron generation in the hippocampus region of mouse brains. They found that the protein amyloid-beta, implicated in causing Alzheimer’s, can induce dysfunctional neuron generation by damaging mitochondria in a way that affects the activity of a gene-regulating protein called KDM5A. The research reveals a central role for mitochondria of neural stem cells in neuron generation, and suggests that drugs supporting mitochondrial function might offer a new approach to treat Alzheimer’s and perhaps other degenerative brain diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Seoul National University, Department of Biomedical Science, College of Medicine, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University College of Medicine, Dementia Research Center, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
2 Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany (GRID:grid.4709.a) (ISNI:0000 0004 0495 846X); Seoul National University, Department of Biological Sciences, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
3 Korea University, Department of Chemistry, Center for Proteogenome Research, Seoul, Korea (GRID:grid.222754.4) (ISNI:0000 0001 0840 2678)
4 Drug Discovery Center, LG Chem Life Science R&D Campus, Seoul, Korea (GRID:grid.464630.3) (ISNI:0000 0001 0696 9566)
5 Chungnam National University, Graduate School of New Drug Discovery & Development, Daejeon, Korea (GRID:grid.254230.2) (ISNI:0000 0001 0722 6377)
6 Seoul National University, Department of Biomedical Science, College of Medicine, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
7 Daegu Gyeongbuk Institute of Science and Technology, Department of Brain and Cognitive Sciences, Daegu, Korea (GRID:grid.417736.0) (ISNI:0000 0004 0438 6721)
8 Korea Institute of Science and Technology, Center for Neuroscience, Brain Science Institute, Seoul, Korea (GRID:grid.35541.36) (ISNI:0000000121053345)
9 Korea Institute of Toxicology (KIT), Department of Predictive Toxicology, Daejeon, Korea (GRID:grid.418982.e) (ISNI:0000 0004 5345 5340)
10 Seoul National University, Department of Biomedical Science, College of Medicine, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905); Seoul National University, Medical Research Center, Genomic Medicine Institute (GMI), Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)
11 Seoul National University, Department of Biological Sciences, Seoul, Korea (GRID:grid.31501.36) (ISNI:0000 0004 0470 5905)